Halozyme Therapeutics (HALO) Earnings Date, Estimates & Call Transcripts → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free HALO Stock Alerts $43.15 -0.69 (-1.57%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (Feb. 20) $0.75 Missed By -$0.02 Consensus EPS (Feb. 20) $0.77 Get Halozyme Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for HALO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueHALO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HALO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Halozyme Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$0.58$0.77$0.69 Q2 20243$0.64$0.92$0.77 Q3 20243$0.85$0.98$0.93 Q4 20243$0.94$1.25$1.05 FY 202412$3.01$3.92$3.43 Q1 20251$0.85$0.85$0.85 Q2 20251$0.90$0.90$0.90 Q3 20251$1.01$1.01$1.01 Q4 20251$1.15$1.15$1.15 FY 20254$3.91$3.91$3.91 Q1 20261$1.21$1.21$1.21 HALO Earnings Date and InformationHalozyme Therapeutics last announced its quarterly earnings data on February 20th, 2024. The biopharmaceutical company reported $0.75 earnings per share for the quarter, missing analysts' consensus estimates of $0.77 by $0.02. The firm earned $230.04 million during the quarter, compared to analyst estimates of $235.25 million. Halozyme Therapeutics has generated $2.42 earnings per share over the last year ($2.42 diluted earnings per share) and currently has a price-to-earnings ratio of 17.8. Earnings for Halozyme Therapeutics are expected to grow by 24.20% in the coming year, from $3.43 to $4.26 per share. Halozyme Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Halozyme Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 2/20/2024Q4 2023$0.77$0.75($0.02)$0.85$235.25 million$230.04 million11/6/2023Q3 2023$0.67$0.69+$0.02$0.77$219.47 million$216.03 million8/8/2023Q2 2023$0.59$0.68+$0.09$0.80$201.91 million$221.04 million5/9/2023Q1 2023$0.44$0.43($0.01)$0.57$174.20 million$162.14 million2/21/2023Q4 2022$0.43$0.44+$0.01$0.46$186.07 million$181.50 million11/8/2022Q3 2022$0.49$0.70+$0.21$0.96$187.87 million$208.98 million Get the Latest News and Ratings for HALO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022$0.47$0.50+$0.03$0.84$156.00 million$152.37 million 5/10/2022Q1 2022$0.45$0.43($0.02)$0.43$128.25 million$117.30 million 2/22/2022Q4 2021$0.35$0.39+$0.04$0.32$97.10 million$102.00 million11/2/2021Q3 2021$0.42$1.48+$1.06($0.44)$101.94 million$115.83 million 8/9/2021Q2 2021$0.43$0.62+$0.19$0.64$104.08 million$136.50 million Halozyme Therapeutics Earnings - Frequently Asked Questions When is Halozyme Therapeutics's earnings date? Halozyme Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on HALO's earnings history. Did Halozyme Therapeutics beat their earnings estimates last quarter? In the previous quarter, Halozyme Therapeutics (NASDAQ:HALO) missed the analysts' consensus estimate of $0.77 by $0.02 with a reported earnings per share (EPS) of $0.75. Learn more on analysts' earnings estimate vs. HALO's actual earnings. How much revenue does Halozyme Therapeutics generate each year? Halozyme Therapeutics (NASDAQ:HALO) has a recorded annual revenue of $829.25 million. How much profit does Halozyme Therapeutics generate each year? Halozyme Therapeutics (NASDAQ:HALO) has a recorded net income of $281.59 million. HALO has generated $2.42 earnings per share over the last four quarters. What is Halozyme Therapeutics's price-to-earnings ratio? Halozyme Therapeutics (NASDAQ:HALO) has a trailing price-to-earnings ratio of 17.83 and a forward price-to-earnings ratio of 12.58. The price/earnings-to-growth ratio is 0.48. What is Halozyme Therapeutics's EPS forecast for next year? Halozyme Therapeutics's earnings are expected to grow from $3.43 per share to $4.26 per share in the next year, which is a 24.20% increase. More Earnings Resources from MarketBeat Related Companies: EXEL Earnings Date RGEN Earnings Date RLAY Earnings Date NVAX Earnings Date ALLO Earnings Date ADPT Earnings Date FATE Earnings Date KOD Earnings Date NBIX Earnings Date IBRX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:HALO) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.